Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

PURPOSE: With three available chemotherapy drugs for advanced colorectal cancer (CRC), response rate (RR) and survival outcomes have improved with associated morbidity, accentuating the need for tools to select optimal individualized treatment. Pharmacogenetics identifies the likelihood of adverse e...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: McLeod, Howard L., Sargent, Daniel J., Marsh, Sharon, Green, Erin M., King, Cristi R., Fuchs, Charles S., Ramanathan, Ramesh K., Williamson, Stephen K., Findlay, Brian P., Thibodeau, Stephen N., Grothey, Axel, Morton, Roscoe F., Goldberg, Richard M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2010
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903324/
https://ncbi.nlm.nih.gov/pubmed/20530282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.7943
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg